"Learn how you can get comprehensive cancer care services in a patient-centered environment at Avera Cancer Institute in Aberdeen, SD."

During the past decade, Avera Cancer Institute-Aberdeen conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 33 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 22 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Avera Cancer Institute-Aberdeen" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avera Cancer Institute-Aberdeen" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Avera Cancer Institute-Aberdeen" are "Breast Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Avera Cancer Institute-Aberdeen" in a lesser frequency.

Most popular intervention types in "Avera Cancer Institute-Aberdeen" are "Drug" (51 trials), "Other" (43 trials), "Biological" (25 trials), "Procedure" (9 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (18 trials), "Questionnaire Administration" (9 trials), "Docetaxel" (8 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Avera Cancer Institute-Aberdeen" are 42 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Avera Cancer Institute-Aberdeen". undefined are not yet recruiting, 9 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Avera Cancer Institute-Aberdeen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Avera Cancer Institute-Aberdeen, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".